Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01849822 · ClinicalTrials.gov registry record · NA
Providing Brain Control of Extracorporeal Devices to Patients With Quadriplegia
A NA study, sponsored by Richard A. Andersen, PhD.
- Completed
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT01849822 is a NA study that has completed, run by Richard A. Andersen, PhD. The registered enrollment target is 1 participants.
The verdict
NCT01849822, a NA study, has completed, sponsored by Richard A. Andersen, PhD.
- COMPLETED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
This research study is being done to develop a brain controlled medical device, called a brain-machine interface or BMI, that will provide people with a spinal cord injury some ability to control an external device such as a computer cursor or robotic limb by using their thoughts. Developing a brain-machine interface (BMI) is very difficult and currently only limited technology exists in this area of neuroscience. The device in this study involves implanting very fine recording electrodes into areas of the brain that are known to create arm movement plans and provide hand grasping information. These movement and grasp plans would then normally be sent to other regions of the brain to execute the actual movements. By tying into those pathways and sending the movement plan signals to a computer instead, the investigators can translate the movement plans into actual movements by a computer cursor or robotic limb. The device being used in this study is called the NeuroPort Array and is surgically implanted in the brain. This device and the implantation procedure are experimental which means that it has not been approved by the Food and Drug Administration (FDA). One NeuroPort Array consists of a small grid of electrodes that will be implanted in brain tissue with a small cable that runs from the electrode grid to a small hourglass-shaped pedestal. This pedestal is designed to be attached to the skull and protrude though the scalp to allow for connection with the computer equipment. The investigators hope to learn how safe and effective the NeuroPort Array is in controlling computer generated images and real world objects, such as a robotic arm, using imagined movements of the arms and hands. To accomplish this goal, two NeuroPort Arrays will be used.
Interventions
- DEVICE Neural Prosthetic System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2013-02 |
| Est. Completion | 2019-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01849822
The ClinicalTrials.gov registry entry for NCT01849822 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Richard A. Andersen, PhD, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Neural Prosthetic System is the first listed.
NCT01849822 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01849822 about?
NCT01849822 is a clinical study titled "Providing Brain Control of Extracorporeal Devices to Patients With Quadriplegia". This research study is being done to develop a brain controlled medical device, called a brain-machine interface or BMI, that will provide people with a spinal cord injury some ability to control an external device such as a computer cursor or robotic limb by using their thoughts. Developing a brai...
What is the current status of trial NCT01849822?
This trial is currently completed. It is a NA study. The enrollment target is 1 participants. The study started on 2013-02. Estimated completion is 2019-01.
What interventions are being tested in trial NCT01849822?
The interventions under investigation include: Neural Prosthetic System (DEVICE).
Who is sponsoring clinical trial NCT01849822?
This trial is sponsored by Richard A. Andersen, PhD, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.